BE1002937A5 - Utilisation d'une source de nucleobase pour la stimulation de la fonction immunitaire et compositions pharmaceutiques et alimentaires correspondantes. - Google Patents

Utilisation d'une source de nucleobase pour la stimulation de la fonction immunitaire et compositions pharmaceutiques et alimentaires correspondantes. Download PDF

Info

Publication number
BE1002937A5
BE1002937A5 BE8900260A BE8900260A BE1002937A5 BE 1002937 A5 BE1002937 A5 BE 1002937A5 BE 8900260 A BE8900260 A BE 8900260A BE 8900260 A BE8900260 A BE 8900260A BE 1002937 A5 BE1002937 A5 BE 1002937A5
Authority
BE
Belgium
Prior art keywords
stimulation
immune function
nucleobase
food compositions
corresponding pharmaceutical
Prior art date
Application number
BE8900260A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002937A5 publication Critical patent/BE1002937A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
BE8900260A 1988-03-11 1989-03-10 Utilisation d'une source de nucleobase pour la stimulation de la fonction immunitaire et compositions pharmaceutiques et alimentaires correspondantes. BE1002937A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16686688A 1988-03-11 1988-03-11

Publications (1)

Publication Number Publication Date
BE1002937A5 true BE1002937A5 (fr) 1991-09-03

Family

ID=22604997

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900260A BE1002937A5 (fr) 1988-03-11 1989-03-10 Utilisation d'une source de nucleobase pour la stimulation de la fonction immunitaire et compositions pharmaceutiques et alimentaires correspondantes.

Country Status (9)

Country Link
JP (1) JPH01279835A ( )
BE (1) BE1002937A5 ( )
CH (1) CH681203A5 ( )
DE (1) DE3907842A1 ( )
FR (1) FR2628320A1 ( )
GB (1) GB2216416B ( )
IT (1) IT1232819B ( )
NL (1) NL8900581A ( )
SE (1) SE8900835L ( )

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2529605B2 (ja) * 1989-10-23 1996-08-28 株式会社大塚製薬工場 免疫賦活剤
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US5488039A (en) * 1994-01-10 1996-01-30 Abbott Laboratories Method for the production of an enteral formula containing ribo-nucleotides
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6706691B1 (en) 1998-07-15 2004-03-16 Board Of Regents, The University Of Texas System Immunosupportive drug sparing diet
ES2219182B1 (es) * 2003-05-12 2005-10-01 Jose Luis Concellon Martinez Procedimiento para compensar el efecto negativo en la salud de alimentos que contienen azucar refinado.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154397A1 (en) * 1971-04-08 1973-05-11 Erba Carlo Spa Nutritive milk additive - to simulate mother's milk contains a high content of nucleic acids
EP0107161A2 (de) * 1982-10-26 1984-05-02 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS385291B1 ( ) * 1960-09-07 1963-05-07
US3231385A (en) * 1960-12-29 1966-01-25 Takeda Chemical Industries Ltd Dairy products
IL29066A (en) * 1966-12-23 1972-11-28 Merck & Co Inc Pharmaceutical preparations containing multi-chain poly-nucleotides to encourage interferon production in humans, animals or cell cultures
DE1617545C2 (de) * 1967-06-19 1983-11-03 Diether Prof. Dr. Bern Jachertz Verwendung von informatorischer Ribonucleinsäure als Vaccine
GB1254744A (en) * 1969-06-19 1971-11-24 Beecham Group Ltd Antiviral ribonucleic acid substance
DE1941942A1 (de) * 1969-08-18 1971-03-04 Sylven Bengt Prof Dr Neues pharmazeutisches Mittel
US3914450A (en) * 1973-04-09 1975-10-21 Anheuser Busch Concentrated extract of yeast and processes of making same
GB1363398A (en) * 1973-03-29 1974-08-14 Yamasa Shoyu Kk Uridine-5.-monophosphate compositions
FR2353293A1 (fr) * 1976-06-03 1977-12-30 Beljanski Mirko Polyribonucleotides ayant une activite dans la genese des leucocytes et des plaquettes sanguines
FR2374911A1 (fr) * 1976-12-21 1978-07-21 Fabre Sa Pierre Adjuvants d'immunite non specifique
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
JPS59219235A (ja) * 1983-05-30 1984-12-10 Mitsui Toatsu Chem Inc 消化性潰瘍用剤
JPS608307A (ja) * 1983-06-28 1985-01-17 Ube Ind Ltd 補強ポリブタジエンの製造法
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
EP0196530A3 (de) * 1985-03-26 1989-03-22 CTA Finanz AG Mittel und Verfahren zur Beschleunigung des Wachstums, zur Optimierung der Fruchtbarkeit und zur Stimulierung des Immunsystems bei Mensch und Tier
JPH0669953B2 (ja) * 1985-08-16 1994-09-07 日産化学工業株式会社 脳脊髄系神経栄養剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154397A1 (en) * 1971-04-08 1973-05-11 Erba Carlo Spa Nutritive milk additive - to simulate mother's milk contains a high content of nucleic acids
EP0107161A2 (de) * 1982-10-26 1984-05-02 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ADV. EXP. MED. BIOL., vol. 165, partie B, 1984, pages 175-178; F.B. RUDOLPH et al.: "Involvement of dietary nucleotides in T lymphocyte function" *
ADV. EXP. MED. BIOL., vol. 195A, no.: Pyrimidine Metab. Man 5, pt. A, 1986, pages 497-501; F.B. RUDOLPH et al.: "Effect of dietary nucleotides on lymphocyte maturation" *
ARCH. SURG., vol. 121, no. 2, février 1986, pages 169-172; A.D. KULKARNI et al.: "Influence of dietary nucleotide restriction on bacterial sepsis and phagocytic cell function in mice" *
CHEMICAL ABSTRACTS, vol. 104, no. 23, 9 juin 1986, page 645, abrégé no. 206041p, Columbus, Ohio, US; A.D. KULKARNI et al.: "Effect of dietary nucleotides on response to bacterial infections", & J. PARENTER. ENTERAL NUTR. 1986, 10(2), 169-71 *
CHEMICAL ABSTRACTS, vol. 108, no. 9, 29 février 1988, page 530, abrégé no. 73587e, Columbus, Ohio, US; A.D. KULKARNI et al.: "Modulation of delayed hypersensitivity in mice by dietary nucleotide restriction", & TRANSPLANTATION 1987, 44(6), 847-9 *
J.E.F. REYNOLDS: "Martindale, the extra pharmacopoeia", edition 28, 1982, The Pharmaceutical Press, London, GB *
TRANSPLANTATION PROCEEDINGS, vol. XIX, no. 4, suppl. 5 août 1987, pages 57-59; C.T. VAN BUREN et al.: "Nucleotide-free diet and suppression of immune response" *

Also Published As

Publication number Publication date
IT8947733A0 (it) 1989-03-10
JPH01279835A (ja) 1989-11-10
GB2216416A (en) 1989-10-11
SE8900835L (sv) 1989-09-12
CH681203A5 ( ) 1993-02-15
FR2628320A1 (fr) 1989-09-15
GB8905179D0 (en) 1989-04-19
GB2216416B (en) 1992-06-24
NL8900581A (nl) 1989-10-02
DE3907842A1 (de) 1989-09-21
SE8900835D0 (sv) 1989-03-09
IT1232819B (it) 1992-03-05

Similar Documents

Publication Publication Date Title
BE1002937A5 (fr) Utilisation d'une source de nucleobase pour la stimulation de la fonction immunitaire et compositions pharmaceutiques et alimentaires correspondantes.
ES2170065T3 (es) Modulacion de la proteina quinasa c por oligonucleotidos.
Cutilletta et al. Muscle and non-muscle cell RNA polymerase activity during the development of myocardial hypertrophy
FR2700117B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
MA27153A1 (fr) Formulations pharmaceutiques de derives de platine
BE900660A (fr) Composition therapeutique pour le traitement des sequelles d'intoxication.
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
RU92016244A (ru) Производные сахарина-ингибиторы протеолитических ферментов
HUP0004780A2 (hu) Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében
WO1999015643A3 (en) ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE
BE901301A (fr) 5-pyrimidine-carboxamides et thiocarboamides, ainsi que le traitement de la leucemie et des tumeurs avec ces substances.
Rydberg et al. Human cells contain protein specifically binding to a single 1, N6-ethenoadenine in a DNA fragment.
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups
FR2625099B1 (fr) Proteines et leur procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees et compositions pharmaceutiques utiles dans la prevention de la toxoplasmose
RU94002476A (ru) Лекарственное средство
EP0733640A4 (en) TWO-YEAR OLIGONUCLEOTIDE AND CARCINOSTATIC AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT
TNSN95068A1 (fr) Oligonucleotides pour inhiber le role des isoprenyl proteine transferases
Obe et al. The restriction endonuclease Alu I induces chromosomal aberrations in human peripheral lymphocytes in vitro
FR2401132A1 (fr) Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant
NL193614B (nl) Werkwijze voor de bereiding van 4,5-tri- en -tetramethyleen-4-isothiazoline-3-onen, 2-alkyl- of -aralkylthio-1-cycloalkeencarbonamiden ten gebruike bij deze werkwijze en werkwijze voor de bereiding van de 2-alkyl- of -aralkylthio-1-cycloalkeencarbonamiden.
WO1998039429A3 (en) Compositions for treatment of disorders involving programmed cell death
FR2603040B1 (fr) Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose
BE876968A (fr) Preparation pharmaceutique pour le traitement therapeutique d'anomalies sexuelles sous forme de frigidite ou d'impuissance
EP0250115A3 (en) 2,5-pyrrolidine dione derivatives obtained from bacteriae, and their use as bactericides
KR880001630A (ko) 5-플루오로우라실 유도체 및 그의 용도

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM

Effective date: 19960331